Industry
Foundations Fund Fast-Track Development of Ebola Test
Cepheid, a leading molecular diagnostics company, has announced the award of a grant of up to USD 3.3 million co-financed by the Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation to quickly develop its “Xpert Ebola” test for use in regions worst hit by the epidemic. Cepheid expects to deliver a prototype in as little as eight weeks. More...07 Dec 2014
Women’s Health Diagnostics Grows to USD 8 Billion Sector
Kalorama Information estimates the market for women’s healthcare diagnostics to be USD 8.4 billion, according to its latest report. The report says the female population can benefit from earlier disease detection and tests taking the form of imaging, surgical, and in vitro approaches. More...30 Nov 2014
Oncology Companion Diagnostics Sector Grows to Over USD 1 Billion
The market for diagnostic test and pharmaceutical drug pairs for cancer treatment has grown significantly, according to the report “Companion Diagnostic Markets” from healthcare market research firm Kalorama Information. More...24 Nov 2014
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
In Other News
Eurofins Genomics Buys VBC-Biotech Businesses, Establishes Austrian Subsidiary
Aperiomics Launches Novel NGS Services
Distribution Agreement Will Streamline Methotrexate Determinations
Blood Sector Continues to Experience Solid Growth
Partners to Develop Rapid Ebola Point-of-Care Test
Tumor BRAC Analysis CDx Lab Established in Europe
Ventana to Develop Companion Diagnostics for ImmunoGen Anticancer Agents
ERBA Diagnostics Enters Brazilian Sector with Leading-Edge Clinical Testing Portfolio
French-German Cooperation to Improve Personalized Cancer Care
BD Advances Entry into NGS with Acquisition of GenCell Biosystems
GlaxoSmithKline Boosts Global Cancer Testing With GE Healthcare Deal
Emergency Approval of Ebola Test Suggests Opportunity for Test Makers
EKF and Mass. General Collaborate to Develop Blood Tests for Cancer Patients
Merck KGaA to Buy Sigma-Aldrich for USD 17 Billion
Initiative Launched to Make Genetic Profiles a Routine Part of Clinical Decisions
Funding Awarded to Develop Diagnostic Point-of-Care Device for Sickle Cell Disease
First European Company Obtains CE-IVD Marking for Next Generation Sequencing in Routine Testing
Physician Office IVD Sector Nears USD 2.5 Billion
Newly CE-Marked Automated Respiratory Disease Assay Now Available
Illumina Partners with Pharmaceutical Companies to Develop Companion Diagnostics
Companion Testing Sector Increased Significantly in 2013
New Partnership Designed to Automate Dystrophin Measurement
Most IVD Sector Companies Look Outside the EU and USA for Growth
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.